Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Revenue | 80M | 133M | 160M | 161M | 208M | 251M |
| Cost of revenue | 75M | 123M | 146M | 150M | 191M | 229M |
| Gross profit | 6M | 9M | 14M | 11M | 17M | 22M |
| Research and development | 886,000 | 788,000 | 986,000 | 1M | 947,000 | 964,000 |
| Selling, general and administrative | 6M | 5M | 8M | 7M | 8M | 11M |
| Operating expenses | 15M | 16M | 22M | 22M | 26M | 32M |
| Operating income | −9M | −7M | −8M | −12M | −9M | −10M |
| Interest expense | — | — | — | — | — | 5M |
| Pre-tax income | −10M | −11M | −11M | −15M | −14M | −14M |
| Income tax | 16,000 | 380,000 | 30,000 | 37,000 | 24,000 | −54,000 |
| Net income | −10M | −12M | −11M | −15M | −14M | −14M |
| Earnings per share | −0.22 | −0.37 | −0.39 | −0.55 | −0.49 | −0.50 |
| Earnings per share, diluted | −0.22 | −0.37 | −0.39 | −0.55 | −0.49 | −0.50 |
| Weighted average shares | 46M | 31M | 28M | 28M | 27M | 27M |
| Weighted average shares, diluted | 46M | 31M | 28M | 28M | 27M | 27M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 41M | 27M | 31M | 23M | 31M | 43M | 49M | 57M |
| Receivables | 8M | 8M | 7M |
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 9M | — | — | −10M | — | — |
| Depreciation and amortisation | 287,000 | 200,000 | 300,000 | 206,000 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 8M |
| 6M |
| 4M |
| 6M |
| 7M |
| Inventory | 75M | 94M | 162M | 213M | 211M | 214M | 256M | 308M |
| Current assets | 127M | 132M | 206M | 250M | 255M | 294M | 323M | 391M |
| Property, plant and equipment | 14M | 15M | 9M | 10M | 10M | 9M | 5M | 4M |
| Total assets | 150M | 155M | 223M | 268M | 274M | 313M | 338M | 407M |
| Current liabilities | 76M | 89M | 156M | 230M | 226M | 251M | 263M | 320M |
| Total liabilities | 104M | 117M | 184M | 243M | 240M | 265M | 274M | 329M |
| Equity | 46M | 38M | 40M | 25M | 34M | 48M | 65M | 78M |
| 200,000 |
| 100,000 |
| Share-based compensation | 942,000 | — | — | 2M | — | — |
| Capital expenditure | 19,000 | — | — | 994,000 | — | — |
| Investing cash flow | −2,000 | — | — | −994,000 | — | — |
| Financing cash flow | 4M | — | — | −27M | — | — |